Top Markets
#1 Islamic Coin Islamic Coin +155.97%
#2 Siren Siren +37.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.84%
#6 Arowana Arowana +19.40%
#7 OpenEden OpenEden +17.23%
#8 Perle Perle +14.78%
#9 Ocean Protocol Ocean Protocol +13.13%
#10 RedStone RedStone +12.61%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Classifica tra le azioni #31811
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Prezzo delle azioni
$0.90225185
Ultima sincronizzazione: 2025-02-16
Capitalizzazione di mercato
$11.99M
Variazione (1 giorno)
0.48%
Variazione (1 anno)
0.00%
Paese
US
Scambia Endymed Ltd (ENDY)

Categoria

Healthcare
Ricavi di Endymed Ltd (ENDY)
Ricavi nel Sep 2024 TTM: $18.94M
Secondo gli ultimi rapporti finanziari di Endymed Ltd, i ricavi attuali dell'azienda (TTM) sono pari a $18.94M. Nel 2022, l'azienda ha registrato ricavi di $21.33M una diminuzione rispetto a i ricavi dell'anno 2021, che erano pari a $21.78M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Endymed Ltd da 2013 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $18.94M -16.84%
2023 $22.78M 6.77%
2022 $21.33M -2.06%
2021 $21.78M 51.85%
2020 $14.35M -12.78%
2019 $16.45M -10.88%
2018 $18.45M 5.20%
2017 $17.54M 23.08%
2016 $14.25M 10.05%
2015 $12.95M 22.80%
2014 $10.55M 79.94%
2013 $5.86M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 245,821.98%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 136,293.39%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 187,219.85%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 110,737.78%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 34,278.40%
US